Neuroinflammation of the nigrostriatal pathway during progressive 6‐OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging
暂无分享,去创建一个
O. Isacson | F. Cicchetti | A. Brownell | O. Isacson | Y. Chen | E. Livni | Y. I. Chen | F. Cicchetti | A. L. Brownell | K. Williams | Y. I. Chen | E. Livni | K. Williams | Ken Williams
[1] I. Mackenzie. Activated microglia in dementia with Lewy bodies , 2000, Neurology.
[2] G. Bing,et al. Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats , 2000, Neuroscience.
[3] W. Galpern,et al. In vivo PET Imaging in rat of dopamine terminals reveals functional neural transplants , 1998, Annals of neurology.
[4] M. Graeber,et al. New expression of myelomonocytic antigens by microglia and perivascular cells following lethal motor neuron injury , 1990, Journal of Neuroimmunology.
[5] B. Jenkins,et al. Dopamine imaging markers and predictive mathematical models for progressive degeneration in Parkinson's disease. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[6] P. Mcgeer,et al. Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.
[7] P. Mcgeer,et al. The importance of inflammatory mechanisms in alzheimer disease , 1998, Experimental Gerontology.
[8] A. Björklund,et al. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat , 1996, Neuroscience.
[9] G L Brownell,et al. Dopamine fiber detection by [11C]-CFT and PET in a primate model of parkinsonism , 1992, Neuroreport.
[10] Richard S. J. Frackowiak,et al. [3H]PK 11195 and the localisation of secondary thalamic lesions following focal ischaemia in rat motor cortex , 1991, Neuroscience Letters.
[11] P. Mcgeer,et al. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR , 1987, Neuroscience Letters.
[12] M. Menziani,et al. Mapping the peripheral benzodiazepine receptor binding site by conformationally restrained derivatives of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3- isoquinolinecarboxamide (PK11195). , 1997, Journal of medicinal chemistry.
[13] André Syrota,et al. Synthesis of N‐(11C) methyl, N‐(methyl‐1 propyl), (chloro‐2 phenyl)‐1 isoquinoleine carboxamide‐3 (PK 11195): A new ligand for peripheral benzodiazepine receptors , 1984 .
[14] Bruce G. Jenkins,et al. Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease , 1998, Nature Medicine.
[15] A. Bjo¨rklund,et al. Astroglial response in the excitotoxically lesioned neostriatum and its projection areas in the rat , 1987, Neuroscience.
[16] J. Langston,et al. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine exposure , 1999, Annals of neurology.
[17] A. Björklund,et al. Studies on Neuroprotective and Regenerative Effects of GDNF in a Partial Lesion Model of Parkinson's Disease , 1997, Neurobiology of Disease.
[18] A. Członkowska,et al. The Inflammatory Reaction Following 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Intoxication in Mouse , 1999, Experimental Neurology.
[19] R B Banati,et al. PK (‘peripheral benzodiazepine’) – binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK 11195 binding to activated microglia , 1997, Journal of neurocytology.
[20] S. Daniel,et al. Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease , 1998, Movement disorders : official journal of the Movement Disorder Society.
[21] Roger N Gunn,et al. In-vivo measurement of activated microglia in dementia , 2001, The Lancet.
[22] F E Turkheimer,et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen’s encephalitis , 1999, Neurology.
[23] P. Mcgeer,et al. Microglial response to 6-hydroxydopamine-induced substantia nigra lesions , 1989, Brain Research.
[24] M. Abercrombie. Estimation of nuclear population from microtome sections , 1946, The Anatomical record.
[25] Kenneth E. Newhouse,et al. The Metabolism of the Human Brain Studied with Positron Emission Tomography , 1985, The Yale Journal of Biology and Medicine.
[26] W. H. Oertel,et al. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat , 1994, Neuroscience.
[27] O. Isacson,et al. Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease , 2001, The European journal of neuroscience.
[28] Alan C. Evans,et al. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis , 1997, Journal of neuroscience research.
[29] P. Mcgeer,et al. Inflammation in Parkinson's disease. , 2001, Advances in neurology.
[30] P. Damier,et al. Glial cells and inflammation in parkinson's disease: A role in neurodegeneration? , 1998, Annals of neurology.
[31] R Tomczak,et al. In vivo imaging of activated microglia using [11 C]PK11195 and positron emission tomography in patients after ischemic stroke , 2000, Neuroreport.
[32] A. Członkowska,et al. Inflammatory changes in the substantia nigra and striatum following MPTP intoxication , 2000, Annals of neurology.
[33] S. Appel,et al. Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. , 1998, Archives of neurology.
[34] G. L. Watkins,et al. PET Imaging of human gliomas with ligands for the peripheral benzodiazepine binding site , 1989, Annals of neurology.
[35] M. Graeber,et al. Synaptic stripping in the human facial nucleus , 2004, Acta Neuropathologica.
[36] R B Banati,et al. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK11195 , 2000, Neurology.
[37] L. Lue,et al. Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. , 1996, Journal of neuropathology and experimental neurology.
[38] P. Mcgeer,et al. Familial nature and continuing morbidity of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam , 1997, Neurology.